发明名称 |
INHIBITORS OF OSTEOCLAST ACTIVITY FOR TREATING ARTHRITIS |
摘要 |
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form |
申请公布号 |
US2015057250(A1) |
申请公布日期 |
2015.02.26 |
申请号 |
US201414536526 |
申请日期 |
2014.11.07 |
申请人 |
Antecip Bioventures II LLP |
发明人 |
Tabuteau Herriot |
分类号 |
A61K31/675;A61K45/06;A61K31/573 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
1. A co-administration method for treating osteoarthritis comprising orally administering a steroid and zoledronic acid to a human being in need thereof. |
地址 |
New York NY US |